GENERAL24 Sept 2026
Nephrocare shares tumble 5% | What’s driving the decline? | Stock Market News
Nephrocare Health Services shares fell over 5% on Thursday, 24 September, after reports that promoters and investors may sell shares through a block deal worth up to ₹650 crore. The shares are reportedly offered at ₹705 each, about 5% below the previous closing price of ₹741.90. If you hold the stock, treat this as news, not a signal.
Key Statutory Highlights
- Nephrocare Health Services shares fell more than 5% on Thursday, 24 September after reports of a block deal.
- Reports say promoters and investors may sell shares worth up to ₹650 crore, with a base size of ₹400 crore and a ₹250 crore upsize option.
- The shares are reportedly offered at ₹705 each, about 5% lower than the last closing price of ₹741.90.
Actionable Advice for Taxpayers / Founders:If you hold Nephrocare shares, avoid acting only on this news. Check the company's official filings and speak to a registered investment adviser before you buy or sell.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: